24 de septiembre del 2019
On September 23, 2019, Sandoz, Inc. announced issued a voluntary recall of Ranitidine 150mg capsules, and 300mg capsules due to an elevated amount of an unexpected impurity (NDMA) found in the active pharmaceutical ingredient.
Product Name | NDC Number | Lot Nbr. | Expiration Date | Date of Manufacture |
RANITIDINE 150mg Capsules 500 count | 0781-2855-05 | HD1862 | 4/30/2020 | 4/19/2017 |
RANITIDINE 150mg Capsules 500 count | 0781-2855-05 | HP9438 | 9/30/2020 | 9/5/2017 |
RANITIDINE 150mg Capsules 500 count | 0781-2855-05 | HP9439 | 9/30/2020 | 9/6/2017 |
RANITIDINE 150mg Capsules 500 count | 0781-2855-05 | HP9440 | 9/30/2020 | 9/5/2017 |
RANITIDINE 150mg Capsules 60 count | 0781-2855-60 | HC9266 | 4/30/2020 | 4/19/2017 |
RANITIDINE 150mg Capsules 60 count | 0781-2855-60 | HD1865 | 4/30/2020 | 4/19/2017 |
RANITIDINE 150mg Capsules 60 count | 0781-2855-60 | HP9441 | 9/30/2020 | 9/6/2017 |
RANITIDINE 150mg Capsules 60 count | 0781-2855-60 | JK7994 | 8/31/2021 | 8/7/2018 |
RANITIDINE 150mg Capsules 60 count | 0781-2855-60 | JK8659 | 8/31/2021 | 8/7/2018 |
RANITIDINE 300mg Capsules 30 count | 0781-2865-31 | HD8625 | 4/30/2020 | 4/27/2017 |
RANITIDINE 300mg Capsules 30 count | 0781-2865-31 | HD9275 | 4/30/2020 | 4/27/2017 |
RANITIDINE 300mg Capsules 30 count | 0781-2865-31 | HU2207 | 8/31/2020 | 8/24/2017 |
RANITIDINE 300mg Capsules 30 count | 0781-2865-31 | HX6676 | 3/31/2021 | 3/20/2018 |
RANITIDINE 300mg Capsules 30 count | 0781-2865-31 | HX6677 | 3/31/2021 | 3/20/2018 |
Additional information is available on the FDA's website:
Última actualización: 13 de marzo del 2020